Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX<sup>®</sup> recurrence score <26.

Cancer Med · 2019 · PMC6675710 · PMID 31199586

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients who recurred also had a higher risk (OR = 2.0, P = 0.175) for LN involvement (5/18 [28%]) compared to patients who did not recur (47/270 [17%], Table S7 ), although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.